Back to top

Mirati Therapeutics (MRTX) Rises: Stock Moves 11.5% Higher
July 18, 2017

Read MoreHide Full Article

Mirati Therapeutics, Inc. (MRTX - Free Report) was a big mover last session, as the company saw its shares rise over 11% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.30 to $4.05 in the past one-month time frame.

None of the estimates for this stock were revised in the last 30 days and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Currently, Mirati Therapeutics carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Aduro BioTech, Inc. (ADRO - Free Report) , sporting a Zacks Rank #1(Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MRTX going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course. Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Aduro Biotech, Inc. (ADRO) - free report >>

Mirati Therapeutics, Inc. (MRTX) - free report >>


More from Zacks Tale of the Tape

You May Like